"Recover from obesity? Not a matter of willpower. Weight loss pills? Not a take-and-forget"

At the ynet and Yedioth Ahronoth health conference, Prof. Roy Eldor and Dr. Hadar Deskin-Bitan discussed GLP-1 drugs for obesity. They emphasized that obesity is a chronic disease, treatment requires medical supervision, and over 100,000 Clalit insured members receive the drugs, which are not in the health basket for adults.

At the ynet and Yedioth Ahronoth health conference, Prof. Roy Eldor, director of the Institute of Endocrinology at Ichilov, and Dr. Hadar Deskin-Bitan, director of the diabetes field at Clalit, discussed GLP-1 drugs for obesity. Eldor emphasized that obesity is a chronic disease with over 220 complications, and that treatment is not a matter of willpower. Deskin-Bitan explained that the drugs reduce Food Noise and allow "room to live," but require multi-disciplinary support. According to her, over 100,000 Clalit insured members receive the treatments, which are not in the health basket for adults but are available in supplementary insurance. The main side effects are gastrointestinal, and about 30% of patients stop within a month. Eldor recommended a slow dose increase and physical activity alongside treatment.

"Recover from obesity? Not a matter of willpower. Weight loss pills? Not a take-and-forget"